INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

ZNTLZentalis Pharmaceuticals, Inc.

CIK 0001725160

EDGAR filingsOpen in network
Disclosed transactions12
Buys / sells0 / 5
Max Insider Score17
Connections8with evidence

ZNTL · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
KE
Kariuki EnochDirector
ZNTLZentalis Pharmaceuticals, Inc.
Grant or award
A—
57.1K sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Skvarka JanDirector · Jun 18, 2026
  • ← Insider ofevidence
    Kariuki EnochDirector · Jun 18, 2026
  • ← Insider ofevidence
    Johnson David MichaelDirector · Jun 18, 2026
17
SJ
Skvarka JanDirector
ZNTLZentalis Pharmaceuticals, Inc.
Grant or award
A
—
57.1K sh
Jun 16, 2026
Jun 18, 2026
traded Jun 16, 2026
+2d
SEC FORM 4

Evidence

17
JM
Johnson David MichaelDirector
ZNTLZentalis Pharmaceuticals, Inc.
Grant or award
A—
57.1K sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC FORM 4

Evidence

9
CS
Campbell ShannonDirector
ZNTLZentalis Pharmaceuticals, Inc.
Grant or award
A—
114.2K sh
May 26, 2026May 27, 2026
traded May 26, 2026
+1dSEC FORM 4

Evidence

8
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$73K
30.0K sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC FORM 4

Evidence

1
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
6,894 sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC FORM 4

Evidence

1
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$8,086
3,379 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC FORM 4

Evidence

1
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$1,398
556 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC FORM 4

Evidence

5
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$6,477
2,540 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

9
BI
Bruns IngmarChief Medical Officer
ZNTLZentalis Pharmaceuticals, Inc.
Grant or award
A—
365.0K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC FORM 4

Evidence

9
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Grant or award
A—
100.0K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC FORM 4

Evidence

9
BB
Bucher James BChief Legal Officer
ZNTLZentalis Pharmaceuticals, Inc.
Grant or award
A—
100.0K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC FORM 4

Evidence

← Insider ofevidence
Campbell Shannon
Director · May 27, 2026
  • ← Insider ofevidence
    Vultaggio VincentPAO and PFO · Jan 9, 2026
  • ← Insider ofevidence
    Bruns IngmarChief Medical Officer · Jan 9, 2026
  • ← Insider ofevidence
    Bucher James BChief Legal Officer · Jan 9, 2026